Regeneron seeking authorization as a preventative
 

Read this and thought others might be interested
https://www.cnbc.com/2021/04/12/covid-regeneron-to-request-fda-clearance-for-antibody-drug-as-preventative-treatment.html

"Regeneron said it is seeking to expand the use of its treatment in the U.S. after a phase three clinical trial, jointly run by the National Institutes of Health, found the drug reduced the risk of symptomatic infections in individuals by 81%."

Also read about Pfizer working on an antiviral pill a few weeks ago.

https://www.pfizer.com/news/press-release/press-release-detail/pfizer-initiates-phase-1-study-novel-oral-antiviral

Thanks for posting.

Hopefully soon, the whole virus thing with the shutdowns and mask requirements, the political footballing....all of it will be in the national rear view window.

Thanks for the post...

Bamlanivimab only treatment for covid has EUA cancelled. Eli Lilly requested the cancellation.

https://www.msn.com/en-us/news/politics/fda-rescinds-emergency-authorization-for-covid-19-antibody-treatment-bamlanivimab/ar-BB1fJNqa?li=BBnb7Kz


"With the growing prevalence of variants in the U.S. that bamlanivimab alone may not fully neutralize, and with sufficient supply of etesevimab, we believe now is the right time to complete our planned transition and focus on the administration of these two neutralizing antibodies together,"


Regeneron's authorization covered two used together

"Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for casirivimab and imdevimab to be administered together"

https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-monoclonal-antibodies-treatment-covid-19